Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Kinase Inhibitor Screening in Myeloid Malignancies
Jeffrey W. Tyner
Knight Cancer Institute
Knight Cancer Translational Oncology Program
Research output
:
Contribution to journal
›
Review article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Kinase Inhibitor Screening in Myeloid Malignancies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Phosphotransferases
100%
Neoplasms
41%
Point Mutation
20%
Pharmaceutical Preparations
8%
Therapeutics
3%